Efficacy of environmental measures to decrease the risk of hospital-acquired aspergillosis in patients hospitalised in haematology wards P. Berthelot,

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Patterns of delays in diagnosis amongst patients with smear-positive pulmonary tuberculosis at a teaching hospital in Turkey E. Okur, A. Yilmaz, A. Saygi,

Thirty-day mortality of nosocomial systemic bacterial infections according to antibiotic susceptibility in an 800-bed teaching hospital in France D.

L. Boyanova Clinical Microbiology and Infection

Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome J. Guinea, M. Torres-Narbona, P.

C.N. van Ettekoven, D. van de Beek, M.C. Brouwer

Gut bacterial microbiota and obesity

Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients M. Giannella, M. Alonso,

Herpes zoster in non-hospitalized children

An evaluation of clinical stability criteria to predict hospital course in community-acquired pneumonia A.R. Akram, J.D. Chalmers, J.K. Taylor, J. Rutherford,

Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia—a propensity-adjusted analysis G. Choudhury,

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

O. Lortholary, J. -P. Gangneux, K. Sitbon, B. Lebeau, F

R. Cantón Clinical Microbiology and Infection

A. F. Simonetti, C. Garcia-Vidal, D. Viasus, D. García-Somoza, J

Public health significance of invasive mosquitoes in Europe

Nocardiosis in Quebec, Canada, 1988–2008

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013 L.E.B. Nabarro, R.A. Lever, M. Armstrong,

Trends in length of stay, mortality and readmission among patients with community- acquired bacteraemia M. Søgaard, R.W. Thomsen, R.B. Bang, H.C. Schønheyder,

Clinical Microbiology and Infection

M. Nørgaard, H. Larsson, G. Pedersen, H.C. Schønheyder, H.T. Sørensen

Epidemiology of invasive fungal infections due to Aspergillus spp

Impact of antibiotic restrictions: the pharmaceutical perspective

Vector control: a cornerstone in the malaria elimination campaign

Risk factors for systemic emboli in infective endocarditis

C. Denis, L. Poirel, A. Carricajo, F. Grattard, P. Fascia, P

J.P. Donnelly, B.E. De Pauw Clinical Microbiology and Infection

C. Girmenia, P. Guerrisi, A. M. Frustaci, A. Fama, E. Finolezzi, S

A. Solé, P. Morant, M. Salavert, J. Pemán, P. Morales

Sofie Arens, Jan Verhaegen, Ludo Verbist

Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis J. Jung, M.Y. Kim, H.J. Lee, Y.S. Park, S.-O.

Training for the infectious diseases speciality in Norway

An algorithm based on one or two nasal samples is accurate to identify persistent nasal carriers of Staphylococcus aureus P.O. Verhoeven, F. Grattard,

Community-acquired pneumonia: the evolving challenge

B. Gordts Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

C. Fabrizio, A. Procopio Clinical Microbiology and Infection

Microbiological and epidemiological studies of Enterococcus faecium resistant to amoxycillin in a university hospital in eastern France M. Thouverez,

Mathematical modeling of Clostridium difficile infection

Metagenomics and probiotics

Transmission permeability of tuberculosis involving immigrants, revealed by a multicentre analysis of clusters N. Alonso Rodríguez, S. Andrés, E. Bouza,

Previously unknown species of Aspergillus

Laboratory diagnosis of Clostridium difficile disease

Antibacterial drug discovery in the 21st century

Abstracts cont. Clinical Microbiology and Infection

Identification of risk factors associated with nosocomial infection by rotavirus P4G2, in a neonatal unit of a tertiary-care hospital R. Herruzo, F.

Current experience in treating invasive zygomycosis with posaconazole

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Z. Erjavec, H. Kluin-Nelemans, P.E. Verweij

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Serum ferritin levels in West Nile encephalitis

Modelling during an emergency: the 2009 H1N1 influenza pandemic

Update on invasive aspergillosis: clinical and diagnostic aspects

Mixed infection with Beijing and non-Beijing strains in pulmonary tuberculosis in Taiwan: prevalence, risk factors, and dominant strain J.-Y. Wang, H.-L.

J.L. Balcázar Clinical Microbiology and Infection

Community-acquired acute bacterial meningitis in the elderly in Turkey

Bloodstream infections as a marker of community-acquired sepsis severity. Results from the Portuguese community-acquired sepsis study (SACiUCI study)

Impact of antibiotic restrictions: the patient's perspective

CMI readers' survey Clinical Microbiology and Infection

Rajko Saletinger, Mario Poljak, Franc Strle

The future of diagnostic bacteriology

Presentation transcript:

Efficacy of environmental measures to decrease the risk of hospital-acquired aspergillosis in patients hospitalised in haematology wards P. Berthelot, P. Loulergue, H. Raberin, M. Turco, C. Mounier, R. Tran Manh Sung, F. Lucht, B. Pozzetto, D. Guyotat Clinical Microbiology and Infection Volume 12, Issue 8, Pages 738-744 (August 2006) DOI: 10.1111/j.1469-0691.2006.01499.x Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Number of hospital building projects between 1995 and 2001 (Hospital Nord, University Hospital of Saint-Etienne, France). Light grey bars correspond to risk-levels 1–3, and dark grey bars to risk-levels 4 and 5. Risk-levels were defined according to the criteria listed in Table 2. Clinical Microbiology and Infection 2006 12, 738-744DOI: (10.1111/j.1469-0691.2006.01499.x) Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Trends in the occurrence of invasive pulmonary aspergillosis (IPA) cases in the adult haematological unit between 1992 and 2001 (University Hospital of Saint-Etienne, France). Bars correspond to the annual number of cases of IPA; the line represents the trend in patient-days of prolonged neutropenia. Clinical Microbiology and Infection 2006 12, 738-744DOI: (10.1111/j.1469-0691.2006.01499.x) Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions